Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level to capitalize on the growing demand for specialized lab space.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust project pipeline.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and gaining access to a pipeline of potential projects.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of potential tenants.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a repeatable pipeline of deals.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a robust pipeline.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a repeatable pipeline of deals.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to share in the promote.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator involved in the development of new facilities or technologies, sharing in the promote and aligning interests.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator involved in the large-scale SPARC development to share in the promote and future value creation.

Co-GP / Platform:A family office could deploy into New York's life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into New York's life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a strong deal pipeline.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator involved in the development of new lab spaces or research facilities.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.